Hawthorne Health
Roseville, US · 1 known investors
Hawthorne Health operates a network of 12 community-based clinical research sites and offers in-home visits to conduct clinical trials, aiming to improve patient enrollment, retention, and protocol-compliant data. It serves study sponsors across therapeutic areas including cardiovascular, dermatology, immunology, neurology, and rare disease.</parameter> <parameter name="founders">[]
Founders & leadership
JR
Joshua RoseNamed on SEC filing
JA
Jodi AkinNamed on SEC filing
JD
Jonathan DiVincenzoNamed on SEC filing
AC
Antonio ClapsisNamed on SEC filing
Board
LC
Lucy CoassinResigned as director on 02/18/2026.
MM
Maddie MaloneyResigned as director on 02/18/2026.
AJ
Andrea JacksonAppointed as director on 02/18/2026.
RD
Richard DalyAppointed as director on 02/18/2026.
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 2 rounds · 2025–2026
▶$10.7KraisedAug 2026 · 1 investors · Other Health CareRule 506(b)
▶$10.7KraisedAug 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joshua RoseExecutive Officer, Director
- Lucy CoassinDirector
- Jodi AkinDirector
- Jonathan DiVincenzoDirector
- Antonio ClapsisDirector
- Maddie MaloneyDirector
- Andrea JacksonDirector
- Richard DalyDirector
- Amount sold
- $10.7K
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedAug 2026 · 6 investors · Other Health CareRule 506(b)
▶$2.5MraisedAug 2026 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joshua RoseExecutive Officer, Director
- Lucy CoassinDirector
- Jodi AkinDirector
- Jonathan DiVincenzoDirector
- Antonio ClapsisDirector
- Maddie MaloneyDirector
- Andrea JacksonDirector
- Richard DalyDirector
- Offering amount
- $5.5M
- Amount sold
- $2.5M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapUqora29 shared keywordsUqora develops consumer supplements and drink mixes focused on urinary tract and bladder health, using ingredients such as cranberry and D-Mannose. Its product line includes regimens for flushing the urinary tract, bladder support, and vaginal health.
Walgreens28 shared keywordsWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
Companies competing with Hawthorne Health for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Hawthorne Health do?
- Hawthorne Health operates a network of 12 community-based clinical research sites and offers in-home visits to conduct clinical trials, aiming to improve patient enrollment, retention, and protocol-compliant data. It serves study sponsors across therapeutic areas including cardiovascular, dermatology, immunology, neurology, and rare disease.</parameter> <parameter name="founders">[]
- Who are Hawthorne Health's investors?
- Hawthorne Health's investors include P5 Health Ventures.
- How much funding has Hawthorne Health raised?
- Hawthorne Health has disclosed $2.5M raised across 2 rounds.
- Where is Hawthorne Health headquartered?
- Hawthorne Health is headquartered in Roseville, US.